AR049825A1 - Vacuna de una subunidad prrsv - Google Patents
Vacuna de una subunidad prrsvInfo
- Publication number
- AR049825A1 AR049825A1 ARP050102515A ARP050102515A AR049825A1 AR 049825 A1 AR049825 A1 AR 049825A1 AR P050102515 A ARP050102515 A AR P050102515A AR P050102515 A ARP050102515 A AR P050102515A AR 049825 A1 AR049825 A1 AR 049825A1
- Authority
- AR
- Argentina
- Prior art keywords
- prrsv
- dna
- vrsune
- subunity
- orf1
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10071—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58135004P | 2004-06-17 | 2004-06-17 | |
| US11/154,617 US7722878B2 (en) | 2004-06-17 | 2005-06-16 | PRRSV subunit vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR049825A1 true AR049825A1 (es) | 2006-09-06 |
Family
ID=35431312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050102515A AR049825A1 (es) | 2004-06-17 | 2005-06-17 | Vacuna de una subunidad prrsv |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7722878B2 (enExample) |
| EP (1) | EP1755664B1 (enExample) |
| JP (1) | JP2008503221A (enExample) |
| KR (1) | KR20070028431A (enExample) |
| AR (1) | AR049825A1 (enExample) |
| AU (1) | AU2005258092A1 (enExample) |
| BR (1) | BRPI0510930A (enExample) |
| CA (1) | CA2570778A1 (enExample) |
| DK (1) | DK1755664T3 (enExample) |
| ES (1) | ES2546933T3 (enExample) |
| MX (1) | MXPA06014821A (enExample) |
| RU (1) | RU2007101531A (enExample) |
| TW (1) | TW200603825A (enExample) |
| WO (1) | WO2006002193A2 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0839912A1 (en) * | 1996-10-30 | 1998-05-06 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| WO2000053787A1 (en) | 1999-03-08 | 2000-09-14 | Id-Lelystad, Instituut Voor Dierhouderij En Dierg Ezondheid B.V. | Prrsv vaccines |
| ES2388909T3 (es) | 1999-04-22 | 2012-10-19 | The United States Of America, As Represented Bythe Secretary Of Agriculture | Vacuna contra el virus del síndrome respiratorio y reproductivo porcino basada en aislado JA-142 aislada |
| AR049924A1 (es) | 2004-06-18 | 2006-09-13 | Univ Minnesota | Identificacion de organismos viralmente infectados y vacunados |
| US7632636B2 (en) | 2004-09-21 | 2009-12-15 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome isolates and methods of use |
| EP2369001B1 (en) | 2005-06-24 | 2016-08-31 | Regents of the University of Minnesota | PRRS viruses, infectious clones, mutants thereof, and methods of use |
| US8436337B2 (en) * | 2009-05-12 | 2013-05-07 | The State of Oregon Acting By and Through The State Board of Higher Education on Behalf of Oregon State Unitiversity | Amorphous multi-component metallic thin films for electronic devices |
| AR078253A1 (es) | 2009-09-02 | 2011-10-26 | Boehringer Ingelheim Vetmed | Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad |
| MX345188B (es) | 2011-02-17 | 2017-01-20 | Boehringer Ingelheim Vetmedica Gmbh | Nueva cepa del prrsv europea. |
| AU2012217170B2 (en) | 2011-02-17 | 2016-07-28 | Boehringer Ingelheim Vetmedica Gmbh | Commercial scale process for production of PRRSV |
| WO2012129176A1 (en) * | 2011-03-18 | 2012-09-27 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Amorphous multi-component metal/metal oxide nanolaminate metamaterials and devices based thereon |
| JP6101251B2 (ja) | 2011-05-07 | 2017-03-22 | ラボラトリオ アヴィメキシコ エスエー ディーイー シーヴィーLaboratorio Avi−Mex, S.A. De C.V. | ウイルスベクターにおける抗prrs組換えワクチン |
| US9187731B2 (en) * | 2011-07-29 | 2015-11-17 | Boehringer Ingelheim Vetmedica Gmbh | PRRS virus inducing type I interferon in susceptible cells |
| WO2013017568A1 (en) | 2011-07-29 | 2013-02-07 | Boehringer Ingelheim Vetmedica Gmbh | INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF |
| US9099230B2 (en) | 2012-11-12 | 2015-08-04 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State Univesity | Amorphous metal thin-film non-linear resistor |
| US9579373B2 (en) | 2013-03-15 | 2017-02-28 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use |
| JP6886291B2 (ja) | 2013-12-20 | 2021-06-16 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハーBoehringer Ingelheim Vetmedica GmbH | PRRSウイルス変異株、ヨーロッパ型PRRSウイルスcDNAクローンおよびそれらの使用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6773908B1 (en) * | 1992-10-30 | 2004-08-10 | Iowa State University Research Foundation, Inc. | Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
| US6592873B1 (en) * | 1992-10-30 | 2003-07-15 | Iowa State University Research Foundation, Inc. | Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids |
| US20020012670A1 (en) * | 2000-01-26 | 2002-01-31 | Knut Elbers | Recombinant attenuation of porcine reproductive and respiratory syndrome (PRRSV) |
| US6841364B2 (en) * | 2002-01-22 | 2005-01-11 | Protatek International, Inc. | Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof |
-
2005
- 2005-06-16 US US11/154,617 patent/US7722878B2/en active Active
- 2005-06-17 JP JP2007516840A patent/JP2008503221A/ja not_active Withdrawn
- 2005-06-17 AU AU2005258092A patent/AU2005258092A1/en not_active Abandoned
- 2005-06-17 CA CA002570778A patent/CA2570778A1/en not_active Abandoned
- 2005-06-17 ES ES05766550.7T patent/ES2546933T3/es not_active Expired - Lifetime
- 2005-06-17 KR KR1020067026720A patent/KR20070028431A/ko not_active Withdrawn
- 2005-06-17 MX MXPA06014821A patent/MXPA06014821A/es not_active Application Discontinuation
- 2005-06-17 EP EP05766550.7A patent/EP1755664B1/en not_active Expired - Lifetime
- 2005-06-17 WO PCT/US2005/021973 patent/WO2006002193A2/en not_active Ceased
- 2005-06-17 RU RU2007101531/13A patent/RU2007101531A/ru unknown
- 2005-06-17 TW TW094120169A patent/TW200603825A/zh unknown
- 2005-06-17 BR BRPI0510930-2A patent/BRPI0510930A/pt not_active Application Discontinuation
- 2005-06-17 DK DK05766550.7T patent/DK1755664T3/en active
- 2005-06-17 AR ARP050102515A patent/AR049825A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2570778A1 (en) | 2006-01-05 |
| US7722878B2 (en) | 2010-05-25 |
| ES2546933T3 (es) | 2015-09-30 |
| KR20070028431A (ko) | 2007-03-12 |
| AU2005258092A1 (en) | 2006-01-05 |
| DK1755664T3 (en) | 2015-08-24 |
| JP2008503221A (ja) | 2008-02-07 |
| RU2007101531A (ru) | 2008-07-27 |
| US20080038293A1 (en) | 2008-02-14 |
| MXPA06014821A (es) | 2007-03-26 |
| WO2006002193A2 (en) | 2006-01-05 |
| BRPI0510930A (pt) | 2007-11-20 |
| EP1755664A2 (en) | 2007-02-28 |
| TW200603825A (en) | 2006-02-01 |
| WO2006002193A3 (en) | 2006-03-02 |
| EP1755664B1 (en) | 2015-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR049825A1 (es) | Vacuna de una subunidad prrsv | |
| ES2525518T3 (es) | Vacunas virales derivadas de células con niveles reducidos de ADN celular residual | |
| NZ593220A (en) | Immunostimulatory oligonucleotides | |
| HRP20070012A2 (hr) | Imunostimulatorski oligonukleotidni multimeri | |
| CY1110506T1 (el) | Χρηση των τροποποιημενων κυκλοσπορινων για τη θεραπεια των διαταραχων hcv | |
| USD609346S1 (en) | Electric shock device (two-holes-handles typed) | |
| JP2009528027A5 (enExample) | ||
| WO2008016473A3 (en) | Dinucleotide mrna cap analogs | |
| WO2008068631A3 (en) | Vaccines including antigen from four strains of influenza virus | |
| EP2270162A3 (en) | Conserved HBV and HCV sequences useful for gene silencing | |
| BRPI0512878A (pt) | formulações de suspensão de aerossol, com tg 227 ea ou tg 134 a como agente propulsor | |
| TWI249186B (en) | Transfer chamber for cluster system | |
| JP2008503221A5 (enExample) | ||
| ITTO20030659A1 (it) | Struttura di supporto per serbatoi di carburante di motociclette. | |
| DE602005027747D1 (de) | Zum gen-silencing geeignete konservierte hbv- und hcv-sequenzen | |
| ATE541944T1 (de) | Polynukleotidprimer | |
| JP2002525033A5 (enExample) | ||
| NZ603854A (en) | West nile virus vaccine | |
| ITTO20000956A0 (it) | Sistema di alimentazione del carburante per motociclo. | |
| IT1320808B1 (it) | Schienale del sedile di un autoveicolo, particolarmente del sedileposteriore. | |
| CO5660272A2 (es) | Vacunas bovinas con adyuvantes | |
| Kawai | Rokumoto, Kahei, The Formation of the Japanese Legal Culture | |
| JP2007518424A5 (enExample) | ||
| 신동희 | The Concept of Finding Aids | |
| TH76495A (th) | Prrsv ซับยูนิต วัคซีน |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |